Related Experiment Videos
IGF system components as prognostic markers in breast cancer
A V Lee1, S G Hilsenbeck, D Yee
1Department of Medicine, University of Texas Health Science Center at San Antonio, 78284-7884, USA.
Breast Cancer Research and Treatment
|March 27, 1998
Summary
Insulin-like growth factor (IGF) family members regulate breast cancer growth. Measuring IGF expression may indicate prognosis and identify new therapeutic targets for breast cancer treatment.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Insulin-like growth factor (IGF) family members are implicated in regulating breast cancer cell proliferation in vitro.
- Interruption of IGF pathways inhibits IGF-mediated cell proliferation, suggesting a role in cancer progression.
Purpose of the Study:
- To review existing data on the role of IGF family members as indicators of breast cancer prognosis.
- To explore the potential of measuring the entire IGF family for informing breast cancer treatment strategies.
Main Methods:
- Literature review of studies investigating IGF family member expression in breast cancer.
- Analysis of data linking IGF expression levels to disease prognosis and progression.
Main Results:
- Evidence suggests that IGF family members are significant indicators of breast cancer prognosis.
- The collective measurement of the IGF family may offer valuable insights into tumor growth effects.
Conclusions:
- IGF family members play a crucial role in breast cancer growth and progression.
- Assessing IGF family expression collectively could enhance prognostic accuracy and guide therapeutic decisions in breast cancer.